InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Rothfuss Cristin. Director active across 1 company, notably Sarepta Therapeutics, Inc.. Cumulatively, 11 filings have been published. History available since 26 November 2024. The latest transaction was disclosed on 4 September 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations
Cristin Rothfuss is a declarant linked to Sarepta Therapeutics, Inc., where the listed role is EVP, General Counsel. The record shows 10 filings in total, and across the 10 sampled filings the most frequent transaction nature is tax withholding, with a period running from 2024-11-29 to 2026-03-13 and buy and sell amounts shown as EUR 0.